While ALT elevation may be associated with seroclearance of HBV DNA and HBV antigens under NA treatment as well as during the progression of the disease (5, 6), other evidence suggests that elevated ALT in CHB patients without antiviral treatment at baseline can be associated with a significantly increased risk for developing HCC. The gene discussed is GPT; the disease is hepatocellular carcinoma.